Re: Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, et al. Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomized, Multicenter Study. Lancet 2020;395:1208-16.
| Autor: | Evangelista L; Nuclear Medicine Unit, Department of Medicine, University of Padua, Padua, Italy. Electronic address: laura.evangelista@unipd.it., De Salvo GL; Clinical Trials and Biostatistics Unit, IRCCS Istituto Oncologico Veneto, Padova, Italy., Zattoni F; Urology Unit, Academic Medical Centre Hospital, Udine, Italy., Novara G; Department of Surgery, Oncology, and Gastroenterology, Urology Clinic, University of Padua, Padua, Italy. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | European urology oncology [Eur Urol Oncol] 2020 Oct; Vol. 3 (5), pp. 713. Date of Electronic Publication: 2020 Jul 18. |
| DOI: | 10.1016/j.euo.2020.06.013 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect